MedPath

UNIVERSITY OF CHESTER

🇬🇧United Kingdom
Ownership
-
Established
1839-01-01
Employees
1.5K
Market Cap
-
Website
https://www1.chester.ac.uk/

Clinical Trials

10

Active:0
Completed:10

Trial Phases

1 Phases

Not Applicable:10

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (10 trials with phase data)• Click on a phase to view related trials

Not Applicable
10 (100.0%)

Diet, Cardiometabolic Risk (CM) and Menopause Symptoms

Not Applicable
Completed
Conditions
Metabolic Syndrome, Protection Against
Menopause
First Posted Date
2023-03-10
Last Posted Date
2024-06-28
Lead Sponsor
University of Chester
Target Recruit Count
12
Registration Number
NCT05764473
Locations
🇬🇧

University of Chester, Chester, Cheshire, United Kingdom

Comparison of Traditional, Web-based or a Combined Cardiac Rehabilitation Programme

Not Applicable
Completed
Conditions
Cardiovascular Diseases
First Posted Date
2022-04-13
Last Posted Date
2024-08-28
Lead Sponsor
University of Chester
Target Recruit Count
57
Registration Number
NCT05326529
Locations
🇬🇧

University of Derby and Burton NHS Foundation Trust, Burton Upon Trent, Staffordshire, United Kingdom

The Effect of CLA on Obesity, Lung Functions, Lipid Profile and Inflammation in Women With BMI≥25

Not Applicable
Completed
Conditions
Obesity
Lung Functions
Inflammation
Lipid Disorder
First Posted Date
2020-11-23
Last Posted Date
2020-11-23
Lead Sponsor
University of Chester
Target Recruit Count
58
Registration Number
NCT04641494
Locations
🇬🇧

University of Chester, Chester, Cheshire, United Kingdom

A Study to Investigate the Effect of Vitamin D3 Supplementation on Asthma Symptoms in Adults With Asthma (VITDAS)

Not Applicable
Completed
Conditions
Asthma
Vitamin D Deficiency
Nutritional Deficiency
Inflammation
First Posted Date
2019-10-07
Last Posted Date
2022-11-04
Lead Sponsor
University of Chester
Target Recruit Count
32
Registration Number
NCT04117581
Locations
🇬🇧

University of Chester, Chester, Chesire, United Kingdom

Effect of n-3 Fatty Acid Supplementation in Hyperlipidemic Patients Taking Statins

Not Applicable
Completed
Conditions
Cardiovascular Diseases
Dyslipidemias
Hyperlipidemias
First Posted Date
2019-05-23
Last Posted Date
2019-05-23
Lead Sponsor
University of Chester
Target Recruit Count
44
Registration Number
NCT03961763
Locations
🇹🇷

Pax Clinic, İstanbul, Turkey

  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.